Filing Details
- Accession Number:
- 0001127602-15-033821
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-10 19:22:45
- Reporting Period:
- 2015-12-08
- Filing Date:
- 2015-12-10
- Accepted Time:
- 2015-12-10 19:22:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-08 | 9,630 | $0.00 | 433,423 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 25,000 | $27.97 | 458,423 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-08 | 6,384 | $174.10 | 452,039 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-08 | 2,851 | $175.09 | 449,188 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-08 | 463 | $176.19 | 448,725 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-08 | 4,068 | $177.13 | 444,657 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-08 | 3,270 | $178.28 | 441,387 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-08 | 1,764 | $179.20 | 439,623 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-08 | 6,200 | $179.99 | 433,423 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Shares | Acquisiton | 2015-12-08 | 28,888 | $0.00 | 28,888 | $0.00 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-12-08 | 25,000 | $0.00 | 25,000 | $27.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,888 | 2018-12-30 | No | 4 | A | Direct | |
| 15,000 | 2009-03-01 | 2019-01-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,000 | Indirect | By Daughters |
Footnotes
- Grant of restricted stock units that vest as follows: 25% of the shares subject to the award become vested on November 5, 2016, November 5, 2017, November 5, 2018, and November 5, 2019, subject to awardee's continuing to be a service provider on such dates.
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 6,384 shares sold ranging from $173.56 to $174.53 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,851 shares sold ranging from $174.59 to $175.49 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 463 shares sold ranging from $175.65 to $176.32 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,068 shares sold ranging from $176.68 to $177.58 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,270 shares sold ranging from $177.75 to $178.73 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,764 shares sold ranging from $178.78 to $179.72 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 6,200 shares sold ranging from $179.80 to $180.41 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 30, 2018. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 30, 2018, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.
Billionaire Hedge Funds
